Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Total globulin fraction (TGF) is calculated by subtracting serum albumin levels from serum total protein levels. The present study examined whether TGF at diagnosis could forecast all-cause mortality during the disease course in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vas...
Gespeichert in:
Veröffentlicht in: | Journal of clinical medicine 2023-06, Vol.12 (12), p.4170 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 12 |
container_start_page | 4170 |
container_title | Journal of clinical medicine |
container_volume | 12 |
creator | Ha, Jang-Woo Ahn, Sung-Soo Song, Jason-Jungsik Park, Yong-Beom Lee, Sang-Won |
description | Total globulin fraction (TGF) is calculated by subtracting serum albumin levels from serum total protein levels. The present study examined whether TGF at diagnosis could forecast all-cause mortality during the disease course in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The present study included 283 patients with AAV. The variables at AAV diagnosis such as demographic data, AAV-specific data including the Birmingham vasculitis activity score (BVAS), five-factor score (FFS), and laboratory data including ANCA, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) were collected. The number of deceased patients during the follow-up duration based on all-cause mortality was counted. The median age of the 283 AAV patients was 60 years, and 35.7% were men. ANCAs were detected in 228 patients, and the median TGF was 2.9. A total of 39 patients (13.8%) died within a median follow-up duration of 46.9 months. TGF at AAV diagnosis was significantly correlated with ESR and CRP rather than AAV activity. Patients with ANCA positivity exhibited a significantly higher median TGF at AAV diagnosis than those without. Patients with TGF ≥ 3.1 g/dL at AAV diagnosis exhibited a significantly lower cumulative survival rate than those without. Furthermore, in the multivariable Cox hazards model analysis, TGF ≥ 3.1 g/dL (hazard ratio 2.611) was independently associated with all-cause mortality, along with age, male sex, and body mass index. The present study is the first to demonstrate that TGF at AAV diagnosis can forecast all-cause mortality during the disease course in AAV patients. |
doi_str_mv | 10.3390/jcm12124170 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10298886</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A758336833</galeid><sourcerecordid>A758336833</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-c7af64eacb1b28390c85739b3527b8cfdbc84c324b714091fb47b46e5a2a7f7e3</originalsourceid><addsrcrecordid>eNptUsFuEzEQXSEQrUJP3JElLkhoi73erJ0TihZSkIrgULhaY683ceTYwfYW5Z_4SKa0lBThkTWW573n8dNU1XNGzzlf0Ddbs2MNa1om6KPqtKFC1JRL_vjofFKd5byluKRsGyaeVidcYMiOn1Y_r2IBTy581JN3gawSmOJiIFDIOwfrELPLpI-TH8gqJmsgF7L0vu5hypZ8ignprhzIMCUX1qRsLPKyBSwiK2FC1S9QnA0lkx-ubMgyFBfsVFLcb5wn_aHEvYe8c-Z3ScfhUC9zjsZBsQP5Btlgb8XlZ9WTEXy2Z3d5Vn1dvb_qP9SXny8-9svL2rR8XmojYOxaC0Yz3Uh0yci54AvN543Q0oyDNrI1vGm1YC1dsFG3QrednUMDYhSWz6q3t7r7Se_sYLD1BF7tk9tBOqgITj2sBLdR63itGG0WUqKxs-rVnUKK3yebi9q5bKz3EGycssK2aNe1vGMIffkPdIu-BfwfolCOiYbSv6g1eKtcGCM-bG5E1VLMJecdbkSd_weFMVh0NwY7Orx_QHh9SzAp5pzseP9JRtXNgKmjAUP0i2Nf7rF_xon_Aj4Jzio</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2829817200</pqid></control><display><type>article</type><title>Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ha, Jang-Woo ; Ahn, Sung-Soo ; Song, Jason-Jungsik ; Park, Yong-Beom ; Lee, Sang-Won</creator><creatorcontrib>Ha, Jang-Woo ; Ahn, Sung-Soo ; Song, Jason-Jungsik ; Park, Yong-Beom ; Lee, Sang-Won</creatorcontrib><description>Total globulin fraction (TGF) is calculated by subtracting serum albumin levels from serum total protein levels. The present study examined whether TGF at diagnosis could forecast all-cause mortality during the disease course in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The present study included 283 patients with AAV. The variables at AAV diagnosis such as demographic data, AAV-specific data including the Birmingham vasculitis activity score (BVAS), five-factor score (FFS), and laboratory data including ANCA, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) were collected. The number of deceased patients during the follow-up duration based on all-cause mortality was counted. The median age of the 283 AAV patients was 60 years, and 35.7% were men. ANCAs were detected in 228 patients, and the median TGF was 2.9. A total of 39 patients (13.8%) died within a median follow-up duration of 46.9 months. TGF at AAV diagnosis was significantly correlated with ESR and CRP rather than AAV activity. Patients with ANCA positivity exhibited a significantly higher median TGF at AAV diagnosis than those without. Patients with TGF ≥ 3.1 g/dL at AAV diagnosis exhibited a significantly lower cumulative survival rate than those without. Furthermore, in the multivariable Cox hazards model analysis, TGF ≥ 3.1 g/dL (hazard ratio 2.611) was independently associated with all-cause mortality, along with age, male sex, and body mass index. The present study is the first to demonstrate that TGF at AAV diagnosis can forecast all-cause mortality during the disease course in AAV patients.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm12124170</identifier><identifier>PMID: 37373863</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Analysis ; Autoantibodies ; Blood ; Body mass index ; Care and treatment ; Clinical medicine ; Correlation analysis ; Diagnosis ; Disease ; Hospitals ; Hypertension ; Immunosuppressive agents ; Medical examination ; Medical prognosis ; Mortality ; Proteins ; Rheumatology ; Risk factors ; Survival analysis ; Testing ; Transforming growth factors ; Vasculitis</subject><ispartof>Journal of clinical medicine, 2023-06, Vol.12 (12), p.4170</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c435t-c7af64eacb1b28390c85739b3527b8cfdbc84c324b714091fb47b46e5a2a7f7e3</cites><orcidid>0000-0002-8038-3341 ; 0000-0002-9002-9880</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298886/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298886/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37373863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ha, Jang-Woo</creatorcontrib><creatorcontrib>Ahn, Sung-Soo</creatorcontrib><creatorcontrib>Song, Jason-Jungsik</creatorcontrib><creatorcontrib>Park, Yong-Beom</creatorcontrib><creatorcontrib>Lee, Sang-Won</creatorcontrib><title>Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Total globulin fraction (TGF) is calculated by subtracting serum albumin levels from serum total protein levels. The present study examined whether TGF at diagnosis could forecast all-cause mortality during the disease course in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The present study included 283 patients with AAV. The variables at AAV diagnosis such as demographic data, AAV-specific data including the Birmingham vasculitis activity score (BVAS), five-factor score (FFS), and laboratory data including ANCA, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) were collected. The number of deceased patients during the follow-up duration based on all-cause mortality was counted. The median age of the 283 AAV patients was 60 years, and 35.7% were men. ANCAs were detected in 228 patients, and the median TGF was 2.9. A total of 39 patients (13.8%) died within a median follow-up duration of 46.9 months. TGF at AAV diagnosis was significantly correlated with ESR and CRP rather than AAV activity. Patients with ANCA positivity exhibited a significantly higher median TGF at AAV diagnosis than those without. Patients with TGF ≥ 3.1 g/dL at AAV diagnosis exhibited a significantly lower cumulative survival rate than those without. Furthermore, in the multivariable Cox hazards model analysis, TGF ≥ 3.1 g/dL (hazard ratio 2.611) was independently associated with all-cause mortality, along with age, male sex, and body mass index. The present study is the first to demonstrate that TGF at AAV diagnosis can forecast all-cause mortality during the disease course in AAV patients.</description><subject>Analysis</subject><subject>Autoantibodies</subject><subject>Blood</subject><subject>Body mass index</subject><subject>Care and treatment</subject><subject>Clinical medicine</subject><subject>Correlation analysis</subject><subject>Diagnosis</subject><subject>Disease</subject><subject>Hospitals</subject><subject>Hypertension</subject><subject>Immunosuppressive agents</subject><subject>Medical examination</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Proteins</subject><subject>Rheumatology</subject><subject>Risk factors</subject><subject>Survival analysis</subject><subject>Testing</subject><subject>Transforming growth factors</subject><subject>Vasculitis</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNptUsFuEzEQXSEQrUJP3JElLkhoi73erJ0TihZSkIrgULhaY683ceTYwfYW5Z_4SKa0lBThkTWW573n8dNU1XNGzzlf0Ddbs2MNa1om6KPqtKFC1JRL_vjofFKd5byluKRsGyaeVidcYMiOn1Y_r2IBTy581JN3gawSmOJiIFDIOwfrELPLpI-TH8gqJmsgF7L0vu5hypZ8ignprhzIMCUX1qRsLPKyBSwiK2FC1S9QnA0lkx-ubMgyFBfsVFLcb5wn_aHEvYe8c-Z3ScfhUC9zjsZBsQP5Btlgb8XlZ9WTEXy2Z3d5Vn1dvb_qP9SXny8-9svL2rR8XmojYOxaC0Yz3Uh0yci54AvN543Q0oyDNrI1vGm1YC1dsFG3QrednUMDYhSWz6q3t7r7Se_sYLD1BF7tk9tBOqgITj2sBLdR63itGG0WUqKxs-rVnUKK3yebi9q5bKz3EGycssK2aNe1vGMIffkPdIu-BfwfolCOiYbSv6g1eKtcGCM-bG5E1VLMJecdbkSd_weFMVh0NwY7Orx_QHh9SzAp5pzseP9JRtXNgKmjAUP0i2Nf7rF_xon_Aj4Jzio</recordid><startdate>20230620</startdate><enddate>20230620</enddate><creator>Ha, Jang-Woo</creator><creator>Ahn, Sung-Soo</creator><creator>Song, Jason-Jungsik</creator><creator>Park, Yong-Beom</creator><creator>Lee, Sang-Won</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8038-3341</orcidid><orcidid>https://orcid.org/0000-0002-9002-9880</orcidid></search><sort><creationdate>20230620</creationdate><title>Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis</title><author>Ha, Jang-Woo ; Ahn, Sung-Soo ; Song, Jason-Jungsik ; Park, Yong-Beom ; Lee, Sang-Won</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-c7af64eacb1b28390c85739b3527b8cfdbc84c324b714091fb47b46e5a2a7f7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analysis</topic><topic>Autoantibodies</topic><topic>Blood</topic><topic>Body mass index</topic><topic>Care and treatment</topic><topic>Clinical medicine</topic><topic>Correlation analysis</topic><topic>Diagnosis</topic><topic>Disease</topic><topic>Hospitals</topic><topic>Hypertension</topic><topic>Immunosuppressive agents</topic><topic>Medical examination</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Proteins</topic><topic>Rheumatology</topic><topic>Risk factors</topic><topic>Survival analysis</topic><topic>Testing</topic><topic>Transforming growth factors</topic><topic>Vasculitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ha, Jang-Woo</creatorcontrib><creatorcontrib>Ahn, Sung-Soo</creatorcontrib><creatorcontrib>Song, Jason-Jungsik</creatorcontrib><creatorcontrib>Park, Yong-Beom</creatorcontrib><creatorcontrib>Lee, Sang-Won</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ha, Jang-Woo</au><au>Ahn, Sung-Soo</au><au>Song, Jason-Jungsik</au><au>Park, Yong-Beom</au><au>Lee, Sang-Won</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2023-06-20</date><risdate>2023</risdate><volume>12</volume><issue>12</issue><spage>4170</spage><pages>4170-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Total globulin fraction (TGF) is calculated by subtracting serum albumin levels from serum total protein levels. The present study examined whether TGF at diagnosis could forecast all-cause mortality during the disease course in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The present study included 283 patients with AAV. The variables at AAV diagnosis such as demographic data, AAV-specific data including the Birmingham vasculitis activity score (BVAS), five-factor score (FFS), and laboratory data including ANCA, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) were collected. The number of deceased patients during the follow-up duration based on all-cause mortality was counted. The median age of the 283 AAV patients was 60 years, and 35.7% were men. ANCAs were detected in 228 patients, and the median TGF was 2.9. A total of 39 patients (13.8%) died within a median follow-up duration of 46.9 months. TGF at AAV diagnosis was significantly correlated with ESR and CRP rather than AAV activity. Patients with ANCA positivity exhibited a significantly higher median TGF at AAV diagnosis than those without. Patients with TGF ≥ 3.1 g/dL at AAV diagnosis exhibited a significantly lower cumulative survival rate than those without. Furthermore, in the multivariable Cox hazards model analysis, TGF ≥ 3.1 g/dL (hazard ratio 2.611) was independently associated with all-cause mortality, along with age, male sex, and body mass index. The present study is the first to demonstrate that TGF at AAV diagnosis can forecast all-cause mortality during the disease course in AAV patients.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37373863</pmid><doi>10.3390/jcm12124170</doi><orcidid>https://orcid.org/0000-0002-8038-3341</orcidid><orcidid>https://orcid.org/0000-0002-9002-9880</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2077-0383 |
ispartof | Journal of clinical medicine, 2023-06, Vol.12 (12), p.4170 |
issn | 2077-0383 2077-0383 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10298886 |
source | PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Analysis Autoantibodies Blood Body mass index Care and treatment Clinical medicine Correlation analysis Diagnosis Disease Hospitals Hypertension Immunosuppressive agents Medical examination Medical prognosis Mortality Proteins Rheumatology Risk factors Survival analysis Testing Transforming growth factors Vasculitis |
title | Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A45%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Total%20Globulin%20Fraction%20at%20Diagnosis%20Could%20Forecast%20All-Cause%20Mortality%20during%20the%20Disease%20Course%20in%20Patients%20with%20Antineutrophil%20Cytoplasmic%20Antibody-Associated%20Vasculitis&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Ha,%20Jang-Woo&rft.date=2023-06-20&rft.volume=12&rft.issue=12&rft.spage=4170&rft.pages=4170-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm12124170&rft_dat=%3Cgale_pubme%3EA758336833%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2829817200&rft_id=info:pmid/37373863&rft_galeid=A758336833&rfr_iscdi=true |